Xilio Therapeutics XLO
NASDAQ XLO
$7.81 -0.22 (-2.70%)
As of: Oct 23, 2026 · 2:14 PM EDT

Xilio Therapeutics (XLO) Change in Accured Expenses (2020 - 2026)

Updated

Xilio Therapeutics (XLO) posted Change in Accured Expenses of -$1.45 million for Q2 2026, compared with $1.16 million a year earlier.

Analysis

Xilio Therapeutics (XLO) Change in Accured Expenses (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Xilio Therapeutics was $1.25 million; for FY2025, it was -$979,000.

  • In prior years, Xilio Therapeutics' Change in Accured Expenses was -$1.54 million in FY2024, $175,000 in FY2023 (-89.0%), $1.59 million in FY2022 and -$5.62 million in FY2021.
  • Quarterly Change in Accured Expenses has run from a low of -$6.38 million in Q1 2025 to a high of $4.63 million in Q2 2022 over five years.
  • According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$1.54 million (Q1 2026), $928,000 (Q4 2025) and $3.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,128.85 Bn 1,097.43 Bn 19.71 Bn -
2 Johnson & Johnson 634.21 Bn 554.07 Bn 17.30 Bn 2.41 Bn
3 AbbVie 505.78 Bn 478.89 Bn 12.70 Bn 1.20 Bn
4 Merck 357.64 Bn 312.02 Bn 12.21 Bn -
5 Novartis Ag 290.31 Bn 254.30 Bn 11.24 Bn -
6 Astrazeneca 265.38 Bn 239.06 Bn 12.86 Bn -
7 Amgen 238.11 Bn 193.51 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn 338.00 Mn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn -
10 Xilio Therapeutics 151.57 Mn -376.10 Mn - -1.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.45 Mn
Mar 31, 2026 -1.54 Mn
Dec 31, 2025 928,000.00
Sep 30, 2025 3.31 Mn
Jun 30, 2025 1.16 Mn
Mar 31, 2025 -6.38 Mn
Dec 31, 2024 -85,000.00
Sep 30, 2024 -211,000.00
Jun 30, 2024 1.25 Mn
Mar 31, 2024 -2.50 Mn
Dec 31, 2023 1.10 Mn
Sep 30, 2023 2.28 Mn
Jun 30, 2023 664,000.00
Mar 31, 2023 -3.87 Mn
Dec 31, 2022 1.47 Mn
Sep 30, 2022 -3.09 Mn
Jun 30, 2022 4.63 Mn
Mar 31, 2022 -1.43 Mn
Dec 31, 2021 842,000.00
Sep 30, 2021 -300,000.00
API Access

Xilio Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=XLO&period=max&api_key=YOUR_API_KEY